Health News

Obama Addresses Deadly Ebola Outbreak

Posted On September 16, 2014

(Atlanta, GA) -- President Obama is pushing an aggressive effort to combat the deadly Ebola outbreak in West Africa.   Speaking at the U.S. Centers for Disease Control Tuesday afternoon, the President said the chances of an Ebola outbreak in the U.S. are extremely low. He said the U.S. has unique capabilities to help mobilize…

Uninsured Healthcare Rates Fall

Posted On September 16, 2014

(Atlanta, GA) -- Fewer Americans are going without healthcare coverage. New figures from the CDC show the nation's uninsured rate has fallen to its lowest level since the 1990s. Federal heath officials say about 41-million Americans had no insurance when benefits started under the Affordable Care Act. That's nearly four-million less than last year. It's…

Deaths From Painkillers On The Rise, But Slowing

Posted On September 16, 2014

(Undated) -- Deaths from prescription painkiller overdoses continue to rise, but at a surprisingly slower pace. A new study from the Centers For Disease Control show such deaths rose 18-percent every year between 1999 and 2007. Yet from 2007 through 2011, deaths increased by only three percent each year. The CDC credits the slowdown with…

U.S. Sending 3,000 Troops To Liberia For Ebola Fight

Posted On September 16, 2014

(Undated) -- The World Health Organization is outlining the five elements of their plan to stop the Ebola outbreak.   President Obama is expected to announce the U.S. will be sending three-thousand military troops to Liberia to help combat the Ebola outbreak. U.S. officials say the announcement will come today during a visit to the…

Drug Companies Partner Up On Alzheimer’s Drug

Posted On September 16, 2014

(Undated) -- Two major drug makers are partnering up to bring an experimental Alzheimer's drug to the market. AstraZeneca and Eli Lilly struck a deal worth as much as 500-million dollars. The drug is currently in the late-stages of development. The company's will share the cost for development and marketing of the drug.